Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

190
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
190
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

12.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

37
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease.

bioRxiv : the preprint server for biology·2026
Same author

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS.

JCI insight·2026
Same author

Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disorders.

BMC medicine·2026
Same author

Single-cell expression QTL analyses of the human cerebellum reveal vulnerability of oligodendrocytes in essential tremor.

Nature genetics·2026
Same author

Consequences of the Novel ALS-Associated <i>KIF5A</i> Variant c.2993-6C > A for Exon 27 Splicing and Axonal Transport of SFPQ.

Neurology. Genetics·2026

Related Experiment Video

Updated: May 6, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

36.1K

SLC1A2 rs3794087 does not associate with essential tremor.

Jay P Ross1, Sruti Rayaprolu2, Cecily Q Bernales1

  • 1Department of Medical Genetics, University of British Columbia, Vancouver British Columbia, Canada.

Neurobiology of Aging
|October 22, 2013
PubMed
Summary

Genetic analysis of SLC1A2 rs3794087 did not confirm its role as a risk factor for essential tremor (ET) in North America. Further research in diverse populations is needed to clarify SLC1A2

Keywords:
AssociationEssential tremorSLC1A2

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.5K

Related Experiment Videos

Last Updated: May 6, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

36.1K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

12.5K

Area of Science:

  • Neurogenetics
  • Human Genetics
  • Neurology

Background:

  • Essential tremor (ET) is a common neurological disorder with a significant genetic component.
  • Previous studies identified the SLC1A2 rs3794087 variant as a potential risk factor for ET in German and Chinese populations, though with conflicting results.
  • The specific genetic underpinnings of ET susceptibility remain incompletely understood.

Purpose of the Study:

  • To investigate the association between the SLC1A2 rs3794087 single nucleotide polymorphism (SNP) and essential tremor (ET) risk in a North American cohort.
  • To validate or refute the findings from previous European and Asian studies.
  • To contribute to a comprehensive understanding of the genetic architecture of essential tremor.

Main Methods:

  • Genotyping of the SLC1A2 rs3794087 polymorphism in 1347 individuals comprising North American ET patients and healthy controls.
  • Statistical analysis of genotype and allele frequencies to compare cases and controls.
  • Application of established genetic association study methodologies.

Main Results:

  • No statistically significant differences were observed in either genotype or allele frequencies of SLC1A2 rs3794087 between North American ET patients and control subjects (p > 0.36).
  • The observed results do not support the role of this specific SNP in conferring susceptibility to essential tremor within the studied North American population.
  • The findings contrast with prior reports from other ethnic groups, highlighting potential population-specific genetic influences.

Conclusions:

  • The SLC1A2 rs3794087 variant is unlikely to be a significant risk factor for essential tremor in the North American population.
  • Genetic associations for essential tremor may be population-specific, necessitating investigation across diverse ethnic groups.
  • Further research is required to explore other genetic factors and their role in ET pathogenesis.